NURS 6630 PMHNP Final Exams (2022) Exam Elaborations Questions & Answers (Walden University) 2 Questions and Answers Set

NURS 6630
PMHNP
Final Exams
Exam Elaborations Questions & Answers


PMHNP Final Exams
2 Sets of Questions and Answers 2022
Walden University

,  Question 1

1 out of 1 points

What will the PMHNP most likely prescribe to a patient with psychotic aggression who needs to
manage the top-down cortical control and the excessive drive from striatal hyperactivity?

Selected Answer: C.

Antipsychotics

 Question 2

1 out of 1 points

The PMHNP is selecting a medication treatment option for a patient who is exhibiting psychotic
behaviors with poor impulse control and aggression. Of the available treatments, which can help
temper some of the adverse effects or symptoms that are normally caused by D2 antagonism?

Selected Answer: D.

Second-generation, atypical antipsychotics

 Question 3

1 out of 1 points

The PMHNP is discussing dopamine D2 receptor occupancy and its association with aggressive
behaviors in patients with the student. Why does the PMHNP prescribe a standard dose of atypical
antipsychotics?

Selected Answer: C.

The doses are based on achieving 60% D2 receptor occupancy.

 Question 4

1 out of 1 points

Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the patient
with psychosis and aggression?

Selected Answer: A.

There is too high a risk of serious adverse side effects.

 Question 5

1 out of 1 points

,The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the PMHNP
exhibits proper care for this patient? </p?

Selected Answer: C.

Titrating the dose by increasing it every 5–7 days

 Question 6

1 out of 1 points

The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive and impulsive
symptoms by decreasing dopaminergic neurotransmission. Which mood stabilizer will the PMHNP
select?

Selected Answer: A.

Lithium (Lithane)

 Question 7

1 out of 1 points

The parents of a 7-year-old patient with ADHD are concerned about the effects of stimulants on their
child. The parents prefer to start pharmacological treatment with a non-stimulant. Which medication
will the PMHNP will most likely prescribe?

Selected Answer: A.

Strattera

 Question 8

1 out of 1 points

The PMHNP understands that slow-dose extended release stimulants are most appropriate for which
patient with ADHD?

Selected Answer: A.

8-year-old patient

 Question 9

1 out of 1 points

A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What should the
PMHNP include when discussing the side effects with the patient?

Selected Answer: C.

, The medication can affect your blood pressure.

 Question 10

1 out of 1 points

The PMHNP is teaching parents about their child’s new prescription for Ritalin. What will the PMHNP
include in the teaching?

Selected Answer: A.

The second dose should be taken at lunch.

 Question 11

1 out of 1 points

A young patient is prescribed Vyvanse. During the follow-up appointment, which comment made by
the patient makes the PMHNP think that the dosing is being done incorrectly?

Selected Answer: B.

“I am unable to fall asleep at night.”

 Question 12

1 out of 1 points

A 14-year-old patient is prescribed Strattera and asks when the medicine should be taken. What does
the PMHNP understand regarding the drug’s dosing profile?

Selected Answer: B.

The patient will have one or two doses a day.

 Question 13

0 out of 1 points

The PMHNP is meeting with the parents of an 8-year-old patient who is receiving an initial
prescription for D-amphetamine. The PMHNP demonstrates appropriate prescribing practices when
she prescribes the following dose:

Selected Answer: B.

The child will be prescribed a 10-mg tablet.

 Question 14

1 out of 1 points